BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 15, 2026
Home » Authors » Tamra Sami

Tamra Sami

Articles

ARTICLES

Mesoblast's stem cell therapy reduces GI bleeding but misses endpoint in end-stage HF trial

Nov. 13, 2018
By Tamra Sami
PERTH, Australia – Australian regenerative medicine company Mesoblast Ltd.'s allogeneic cell therapy candidate, MPC-150-IM, failed to meet the primary endpoint in a phase IIb trial in end-stage heart failure patients implanted with a left ventricular assist device (LVAD), but it delivered meaningful clinical results that may make it approvable.
Read More

Cochlear ordered to pay $268M to AMF in enhanced damages for patent infringement

Nov. 7, 2018
By Tamra Sami
PERTH, Australia – Australia's Cochlear Ltd. said it would fight a U.S. District Court patent infringement verdict reported Monday that doubles the damages Cochlear was ordered to pay the Alfred E. Mann Foundation for Scientific Research and Advanced Bionics LLC. The Federal District Court for the Central District of California awarded "enhanced damages" in the amount of $268 million, and the cochlear implant company will need to lodge a $335 million insurance bond to appeal the judgement.
Read More

Australia aims to become regenerative medicine hub for the Asia Pacific region

Nov. 7, 2018
By Tamra Sami
BRISBANE, Australia – Australia is considered one of the first movers in the regenerative medicine (RM) space, with more than 70 institutes and companies working in the sector across the country. But to capitalize on its technical capabilities, it will need to be strategic if it is to reach its potential to be a major player in Asia Pacific.
Read More

Australia maps out new CDx regulatory framework that mirrors EU regs

Nov. 7, 2018
By Tamra Sami
PERTH, Australia – Australia’s Therapeutic Goods Administration (TGA) is seeking industry comments on a proposal to introduce a new framework for companion diagnostics.
Read More

Australia aims to become regenerative medicine hub for the Asia Pacific region

Nov. 6, 2018
By Tamra Sami

Australia aims to become regenerative medicine hub for the Asia Pacific region

Nov. 6, 2018
By Tamra Sami
BRISBANE, Australia – Australia is considered one of the first movers in the regenerative medicine (RM) space, with more than 70 institutes and companies working in the sector across the country. But to capitalize on its technical capabilities, it will need to be strategic if it is to reach its potential to be a major player in Asia Pacific.
Read More

Australia maps out new CDx regulatory framework that mirrors EU regs

Nov. 1, 2018
By Tamra Sami
PERTH, Australia – Australia's Therapeutic Goods Administration (TGA) is seeking industry comments on a proposal to introduce a new framework for companion diagnostics.
Read More

Australia maps out new companion diagnostic regulatory framework that mirrors EU regs

Oct. 31, 2018
By Tamra Sami

Australia sets in motion mandatory requirements for patient implant cards

Oct. 25, 2018
By Tamra Sami

Australia launches first oncology registry trials

Oct. 24, 2018
By Tamra Sami
PERTH, Australia – Australia is kicking off its first-ever registry-based randomized controlled trials in oncology to help clinicians select the right treatments for the right patients.
Read More
View All Articles by Tamra Sami

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 14, 2026.
  • Illustration of a glowing circle to represent circRNA

    ASGCT 2026: Circular RNA, the new beast in gene and cell therapy

    BioWorld
    Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
  • Brain maze

    Alzheimer’s, beyond the brain

    BioWorld
    Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
  • Test tubes, dropper and capsules

    Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal

    BioWorld
    In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 12, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing